Understanding and treating developmental brain disorders
Following the failure of the phase 3 of autism treatment, our fundamental research is stopped. the researchers, engineers and technicians had to leave the company, and the equipement is sold.
News
Although the phase III clinical trial was a failure, Neurochlore was able to retrieve data that could be promising. …
IBEN will give a satellite conference at the FENS 2022, an european congress of neurosciences.
The conference, which take place …
Past research
Our research aims at determining brain development alterations that lead to Autism Spectrum Disorders (ASD) and other Neurodevelopmental Disorders and identifying therapeutic targets.